Key Market Indicators
Burma's HIV/AIDS treatment coverage has improved to 84% of people living with HIV, up 6.3 points from 79% in 2020. Since 2010, the market has grown by 9.7 points year-on-year. Burma came in at number 27 in 2021, with Thailand ahead of them at 84%. Cape Verde, Latvia and Zimbabwe are ranked second, third and fourth respectively. The number of people aged 0-14 living with HIV in Burma is expected to reach 12,230 by 2026, growing at a rate of 1.1% year-on-year. Since 1995, the demand has increased by 0.8% annually. In 2021, Burma is ranked 22nd, behind Rwanda with 11,430, Nigeria, Mozambique and Tanzania coming in second, third and fourth respectively.
Myanmar HIV AIDS Market Data and Forecasts
How much will Myanmar HIV AIDS Market grow?
More in HIV AIDS Industry for 2028Improve your Knowledge with the latest Indicators and Trends
-
HIV Treatment Sector: Comprehensive Analysis of Therapeutic Advancements and Opportunities
The modern HIV treatment landscape has been remodelled by the introduction of revolutionary drugs and therapeutic interventions focusing on improved patient compliance and reduced side effects. Antiretroviral therapy (ART) has notably evolved, with a surge of new drug categories, such as integrase inhibitors, showing remarkable efficacy. There has also been...
Discover more insights -
HIV Market Access Impact: Influential Points & Comprehensive Perspectives
The influence within the HIV market is primarily driven by multiple factors. Key among them includes the level of pharmaceutical innovation, the prevalence of the disease, and the nature of funding for treatment and research. Pharmaceutical companies have been more amicable towards investing in the development of groundbreaking treatments, paving...
Discover more insights